Coated-platelets in ischemic stroke: Differences between lacunar and cortical stroke

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 4, 2008, Pages 609-614

  Prodan, Calin I ^a,b,d   Joseph, P M ^b   Vincent, A S ^c   Dale, G L ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d NONE   (United States)

Author keywords

Ischemia; Lacunar; Platelets; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN SCINTISCANNING; CEREBROVASCULAR ACCIDENT; COATED PLATELET; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORTICAL STROKE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SMOKING; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; BRAIN INFARCTION; BRAIN ISCHEMIA; COLLAGEN; COMORBIDITY; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SMOKING; THROMBIN;

EID: 41049083872     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02890.x     Document Type: Article

References (24)

1. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577-617.
2. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen and convulxin. Blood 2000; 95: 1694-702.
3. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 175-9.
4. Szasz R, Dale GL. Thrombospondin and fibrinogen bind serotonin derivatized proteins on COAT-platelets. Blood 2002; 100: 2827-31.
5. Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol 2005; 25: 467-71.
6. Dale GL. Coated-platelets: An emerging component of the procoagulant response. J Thromb Haemostasis 2005; 3: 2185-92.
7. Brooks MB, Catalfamo JL, Friese P, Dale GL. Scott syndrome dogs have impaired coated-platelet formation and calcein-release but normal mitochondrial depolarization. J Thromb Haemostasis 2007; 5: 1972-4.
8. Hamilton SF, Miller MW, Thompson CA, Dale GL. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro. J Lab Clin Med 2004; 143: 320-6.
9. Prodan CI, Joseph PM, Vincent AS, Dale GL. Coated-platelet levels are influenced by smoking, aspirin and selective serotonin reuptake inhibitors. J Thromb Haemostasis 2007; 5: 2149-51.
10. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6.
11. Adams H, Adams R, Del Zoppo G, Goldstein LB; Stroke Council of the American Heart Association; American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36: 916-23.
12. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Stroke 1993; 24: 35-41.
13. Gorelick PB. Cerebrovascular disease in African Americans. Stroke 1998; 29: 2656-64.
14. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA. Stroke incidence among white, black, and Hispanic residents of an urban community: The Northern Manhattan Stroke Study. Am J Epidemiol 1998; 147: 259-68.
15. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, Woo D, Szaflarski J, Gebel J, Moomaw C, Pancioli A, Jauch E, Shukla R, Broderick J. Stroke in a biracial population: The excess burden of stroke among blacks. Stroke 2004; 35: 426-31.
16. Fisher CM. Lacunes: Small, deep cerebral infarcts. Neurology 1965; 15: 774-84.
17. Poirier J, Derouesne C. Le concept de la lacune cerebrale de 1838 a nos jours. Rev Neurol (Paris) 1985; 141: 3-17.
18. Arboix A, Marti-Vilalta JL, Garcia JH. Clinical study of 227 patients with lacunar infarcts. Stroke 1990; 21: 842-7.
19. Wardlaw JM. What causes lacunar stroke? J Neurol Neurosurg Psychiatry 2005; 76: 617-9.
20. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study. Stroke 2001; 32: 2735-40.
21. Bamford JM, Warlow CP. Evolution and testing of the lacunar hypothesis. Stroke 1988; 19: 1074-82.
22. Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q. Testing the validity of the lacunar hypothesis: The Northern Manhattan Stroke Study experience. Neurology 1997; 48: 1204-11.
23. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569-73.
24. Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005; 128: 2507-17.